Amy W Schulman insider trades
Open-market stock purchases and sales by Amy W Schulman, Director at Alnylam Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 25, 2010.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +75%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 20, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| May 20, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| May 13, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| May 13, 2026 | ELV Elevance Health, Inc | Bought (not open market) | — |
| Mar 12, 2026 | ELV Elevance Health, Inc | Sold | $7.5K |
| Feb 2, 2026 | ELV Elevance Health, Inc | Bought (not open market) | — |
Companies traded
- ALNY Alnylam Pharmaceuticals, Inc: 4 sales, last May 20, 2026
- ELV Elevance Health, Inc: 1 sale, last May 13, 2026
- GUTS Fractyl Health, Inc: 1 buy, last Jun 11, 2025
- SQZ SQZ Biotechnologies Co: 3 buys, last Jun 14, 2023
- HCII Hudson Executive Investment Corp II: 1 buy, last Apr 13, 2021
- CYCN Cyclerion Therapeutics, Inc: 2 buys, last Jun 16, 2020
- IRWD Ironwood Pharmaceuticals Inc: other filings, last Apr 1, 2019
- ASNS Arsanis, Inc: other filings, last Jun 5, 2018
- BUFF Blue Buffalo Pet Products, Inc: other filings, last Apr 24, 2018
- BIND BIND Therapeutics, Inc: other filings, last Jun 9, 2015
- PFE Pfizer Inc: 19 sales, last Dec 31, 2013
- ZTS Zoetis Inc: 1 buy, last Feb 6, 2013